BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Monteris Medical, Inc. Secures $9 Million Financing


5/7/2012 8:27:20 AM

WINNIPEG, Manitoba, May 07, 2012 (BUSINESS WIRE) -- Monteris Medical Inc., a privately held medical device company dedicated to the development of innovative MRI guided, laser-based cancer treatments announced today it has secured $9 million in financing to support the continued commercialization of the company's NeuroBlate(TM) System (formerly AutoLITT(R)) within the North American neurosurgery market.

Business Development Bank of Canada (BDC) led the round. Other investors included the SWMF Life Science Fund, a group assembled by Richardson GMP and a number of independent parties.

John E. Schellhorn, President & Chief Executive Officer of Monteris remarks, "We are extremely grateful for the funding and support we have received from BDC, SWMF Life Science Fund, and Richardson GMP. "The timing is right for Monteris to complete development of our new technology platforms, to continue expansion throughout the U.S. Schellhorn concluded, "Our NeuroBlate(TM) System offers neurosurgeons another controlled therapy for difficult-to-treat brain tumors. We are committed to helping them offer critically ill patients hope in the form of MRI guided neurosurgical ablation."

"Monteris Medical is clearly representative of the dynamic, leading-edge technology companies in which BDC invests. We are pleased to have led this round of financing," states Gary Bantle, Partner, Health Venture Fund. "This venture capital investment represents our continued commitment to the Manitoba market and is evidence that good quality opportunities for growth in this sector are still available,"

"The SWMF Life Science Fund has been involved with Monteris since 2008," added Managing Director, Pat Morand. "SWMF was created to support very early stage companies on their path towards commercialization, "It is very satisfying to see how an early stage company can progress when given the resources to do so."

About Monteris Medical

Formed in 1999, Monteris Medical is a privately held medical device company dedicated to the development of innovative MRI guided, laser-based cancer treatments. Monteris Medical markets the NeuroBlate(TM) System, a neurosurgical ablation system providing controlled therapy for difficult-to-treat brain tumors. Monteris also offers the AXiiiS(R) Stereotactic Miniframe; a single use platform for image-guided, stereotactic brain biopsy; and the AtamA(TM) Stabilization System for MRI-guided neurosurgical procedures that require rigid head fixation.

www.monteris.com

About BDC

Canada's business development bank, BDC puts entrepreneurs first. With almost 1,900 employees and more than 100 business centres across the country, BDC offers financing, venture capital and consulting services to 29,000 small and medium sized companies. Their success is vital to Canada's economic prosperity.

www.bdc.ca

About SWMF Life Science Fund

The Southwest Michigan First Life Science Fund is a limited partnership venture fund interested in early stage life science opportunities that have demonstrably viable technologies. The $65 million fund invests primarily in early stage life science companies with a presence or committed to establishing a presence in southwestern Michigan.

www.southwestmichiganfirst.com

About RichardsonGMP

Canada's largest independent wealth management firm with 15 offices across Canada, Richardson GMP Limited provides exclusive and innovative investment solutions to successful families and entrepreneurs. Richardson GMP has earned top overall ranking in the 2010, 2011 and 2012 Investment Executive Brokerage Report Card for products and services dedicated to high net worth investors.

www.richardsongmp.com

SOURCE: Monteris Medical Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES